Vitamin d status and response to daily 400 iu vitamin d3 and weekly alendronate 70 mg in men and women with osteoporosis;Niveles de vitamina d y respuesta a dosis diarias de 400 iu de vitamina d3 y semanales de 70 mg de alendronato en hombres y mujeres canadienses con osteoporosis

Annals of Pharmacotherapy

Volumn 45, Issue 5, 2011, Pages 561-568

  Karaplis, Andrew C ^a   Chouha, Fridon ^b   Djandji, Michel ^c   Sampalis, John S ^d   Hanley, David A ^e  

^a MCGILL UNIVERSITY   (Canada)

^b JSS Medical Research   (Canada)

^c MERCK FROSST CENTRE FOR THERAPEUTIC RESEARCH   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e UNIVERSITY OF CALGARY   (Canada)

Author keywords

25 hydroxyvitamin d (25 OH D); Alendronate; Bisphosphonate; Osteoporosis; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ALENDRONIC ACID; COLECALCIFEROL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONNECTIVE TISSUE DISEASE; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MUSCULOSKELETAL DISEASE; NAUSEA; NEUROLOGIC DISEASE; OSTEOPOROSIS; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; TREATMENT OUTCOME; VITAMIN BLOOD LEVEL;

AGED; ALENDRONATE; BONE DENSITY CONSERVATION AGENTS; CANADA; CHOLECALCIFEROL; COHORT STUDIES; DIETARY SUPPLEMENTS; FEMALE; HUMANS; MALE; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VITAMIN D;

EID: 79957583116     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1P439     Document Type: Article

References (25)

1. National Osteoporosis Foundation. Physician's guide to prevention and treatment of osteoporosis. http://www.nof.org/professionals/NOF_Clinicians_Guide.pdf (accessed 2010 Feb 26).
2. Hanley DA, Josse RG. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 1. Introduction. CMAJ 1996;155:921-923.
3. Tenenhouse A, Joseph L, Kreiger N, et al. Estimation of the prevalence of low bone density in Canadian women and men using a populationspecific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int 2000;11:897-904.
4. Gruntmanis U. Male osteoporosis: deadly, but ignored. Am J Med Sci 2007;333:85-92.
5. Baker MR, McDonnell H, Peacock M, Nordin BE. Plasma 25-hydroxy vitamin D concentrations in patients with fractures of the femoral neck. Br Med J 1979;1:589.
6. Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 1992;327: 1637-1642.
7. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997;337:670-676.
8. Chapuy MC, Preziosi P, Maamer M, et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 1997;7:439-443.
9. Guillemant J, Taupin P, Le HT, et al. Vitamin D status during puberty in French healthy male adolescents. Osteoporos Int 1999;10:222-225.
10. Holick MF, Siris ES, Binkley N, et al. Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 2005;90:3215-3224.
11. Heaney RP, Dowell MS, Hale CA, Bendich A. Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr 2003;22:142-146.
12. Bates CJ, Carter GD, Mishra GD, O'Shea D, Jones J, Prentice A. In a population study, can parathyroid hormone aid the definition of adequate vitamin D status? A study of people aged 65 years and over from the British National Diet and Nutrition Survey. Osteoporos Int 2003;14:152-159.
13. Lips P, Wiersinga A, van Ginkel FC, et al. The effect of vitamin D supplementation on vitamin D status and parathyroid function in elderly infjects. J Clin Endocrinol Metab 1988;67:644-650.
14. Krall EA, Sahyoun N, Tannenbaum S, Dallal GE, Dawson-Hughes B. Effect of vitamin D intake on seasonal variations in parathyroid hormone secretion in postmenopausal women. N Engl J Med 1989;321:1777-1783.
15. Lips P, Duong T, Oleksik A, et al. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. J Clin Endocrinol Metab 2001;86:1212-1221.
16. Rucker D, Allan JA, Fick GH, Hanley DA. Vitamin D insufficiency in a population of healthy western Canadians. CMAJ 2002;166:1517-1524.
17. Hanley DA, Cranney A, Jones G, et al. Guidelines Committee of the Scientific Advisory Council of Osteoporosis Canada. Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada. CMAJ 2010;182:E610-E618.
18. Institute of Medicine. Dietary reference intakes for calcium and vitamin D. Washington, DC: National Academy of Sciences, 2011
19. MacLaughlin J, Holick MF. Aging decreases the capacity of human skin to produce vitamin D. J Clin Invest 1985;76:1536-1538.
20. McKenna MJ, Freaney R. Secondary hyperparathyroidism in the elderly: means to defining hypovitaminosis D. Osteoporos Int 1998;8(suppl 2):S3-S6.
21. Malabanan A, Veronikis IE, Holick MF. Redefining vitamin D insufficiency. Lancet 1998;351:805-6.
22. Cranney A, Horsley T, O'Donnell S, et al. Effectiveness and safety of vitamin D in relation to bone health. A report prepared by the University of Ottawa Evidence-Based Practice Center for the Agency for Healthcare Research and Quality (AHRQ Publication Evidence Report No. 07-E013). Rockville, MD: Department of Health and Human Services. 2007
23. Recker R, Lips P, Felsenberg D, et al. Alendronate with and without cholecalciferol for osteoporosis: results of a 15-week randomized controlled trial. Curr Med Res Opin 2006;22:1745-1755.
24. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006;84:18-28.
25. Khaw KT, Sneyd MJ, Compston J. Bone density parathyroid hormone and 25-hydroxyvitamin D concentrations in middle aged women. BMJ 1992;305:273-277.